chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This report described joint swelling in a 59 year old female who received Lymerix. This report was received as part of the litigation proceedings, with forwarding of medical records. Significant medical history concurrent conditions and concurrent medications taken were not clear from the medical records received. On 16 March 1999 and 18 February 1999 the subject received injections (intramuscularly, in the left deltoid) of Lymerix vaccine. The lot numbers were not recorded. The subject refused a 3rd injection of Lymerix after developing flu like symptoms on 21 march 1999, three days after the 2nd dose of Lymerix. In a statement of injuries, the subject's attorney alleged that the subject suffers and has suffered from joint swelling, joint pain, flu like symptoms, fatigue, gastrointestinal problems, headache, muscle pain, weakness, cognitive difficulty, decreased physical activity, rheumatological symptoms, neurological impairment and immune system disorder following administration of Lymerix. Limited information was available from medical records received on 26 Oct 2006. Details concerning the subjects condition and outcome of the alleged events was not provided. it was reported in the medical records that the events are considered to be related to treatment with Lymerix vaccine. Follow up was received via medical records on 30 January 2007. Medical history included smoker and hyperlipidemia. Medical records dated 08 August 2001 noted that the subject was on Baycol (Cerivastatin) and did have muscle soreness. A neuropathology report from a skin biopsy from the right distal leg performed on 06 February 2006 noted that the skin has significantly reduced epidermal nerve fiber density (2.8 to 3.0 epidermal nerve fiber per millimeter versus 5.0 per millimeter for reference value 5th percentile) consistent with a diagnosis of small nerve fiber neuropathy. The clinical information from the neuropathology report indicated that the subject experienced auto immune post vaccination sensory neuropathy. This case was assessed as medically serious by manufacturer.
a woman who was paralyzed after getting her doses of the Pfizer vaccine.; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received bnt162b2 (BNT162B2), first dose via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose, second dose via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunization. The patient medical and concomitant medications were not reported. The reporter reported that they are doing a story with a woman who was paralyzed on an unspecified date after getting her doses of the Pfizer vaccine. Outcome of the event was unknown.   Information on the lot/batch number has been requested.
Pt comes to the ED with left lower abdominal pain and passing large blood clots. Pt reports some nausea, no vomiting. Pt reports her pain started yesterday and she passed a large clot this morning with increased vaginal bleeding last night. Overnight, she wore a tampon instead of a pad and she woke up this morning in a pool of blood. Pt denies any pregnancy
Case number PHEH2016US023401 is an initial spontaneous report received from a nurse on 13 Sep 2016. This report refers to a 43 year old patient whose gender was not specified. The patient's medical history and concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1515701) at a dose of 0.5 ml intramuscularly in the left arm on 15 Jan 2016. It was reported that the patient received FLUVIRIN multi dose vial (MDV) that had been exposed to 8 to 10 temperature excursion. The patient did not experience any adverse events following vaccination.
Pt states that he started experiencing dizziness around 1330 06 April after he got his second COVID shot around 0945 that morning. His s/x progressed to n/v that evening when he self referred to a health center. He was released and given ant-emetics; likely Zofran. Following day, 07 April, he called his supervisor and stated that he still felt dizzy. His n/v have subsided and dizziness has decreased.
This spontaneous report as received from a nurse refers to a 10 months 16 days old male patient. No concurrent condition, medical history or allergy/drug reactions were reported. On an unspecified date, the patient was vaccinated with improperly stored (exposed to 52.8 Fahrenheit for a total of 105 hours) PEDVAXHIB injection, lot # K016965, exp. date: 20-JUL-2017 (dose, strength and route unspecified). No concomitant medications were reported. No adverse experiences have been reported so far. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information is not expected, no contact details were provided.
impossible take The other dosis; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 21-May-2021 and was forwarded to Moderna on 03-Jun-2021.    Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INTENTIONAL PRODUCT USE ISSUE (impossible take The other dosis) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On an unknown date, the patient experienced INTENTIONAL PRODUCT USE ISSUE (impossible take The other dosis). At the time of the report, INTENTIONAL PRODUCT USE ISSUE (impossible take The other dosis) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitants were reported. No treatment was reported.
JOINT PAIN; CHILLS; FEVER; FATIGUE; This spontaneous report received from a patient via a company representative concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 14-MAR-2021, the subject experienced joint pain. On 14-MAR-2021, the subject experienced chills. On 14-MAR-2021, the subject experienced fever. On 14-MAR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, chills, fatigue and joint pain was not reported. This report was non-serious.
Pt vaccinated with DTP/OPV child in bed w/parents - not breathing - taken to ER Indiana.  Autopsy done - Dx SIDS
approximately 30 seconds after patient received this vaccine she fainted and fell to the floor.  She regained consciousness but then began to vomit.  Symptoms were short lived and 9 hours later she seems to be fine.
Began feeling ill and had fever and chills. Took at home test and it was positive for COVID-19. Reached out to PCP and was prescribed Paxlovid. I felt better within a week of beginning the Paxlovid.
body aches(entire body, including eyeballs) fever 99.8 lasting 24 hours
report from-mother local reaction and swelling/redness took child to Emerg Room, D/T clinic closed already- Tx: Ice pack.
Pt broke out in hives 30 minutes after receving immunizations. Pt was given Benadryl and was monitored in clinic.
Patient reported to the pharmacy 24 hours after receiving vaccine with complaints of arm soreness and concerns of the location the vaccine was administered. Patient was instructed to contact medical provider if the issue continues. Administering pharmacist is confident of the location the vaccine was administered (left deltoid muscle).
Jaw pain 6/29/21 then 7/6/21 Bells Palsy Left side.
VEARS report was completed on member due to yellow fever mixed with the sterile water versus what was suppplied - sodium chloride. Contacted Sanofi Pasteur and there should not be any side effect and they DO NOT recommend a revaccination.
no adverse effects; patient received an improperly stored RECOMBIVAX; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. No information regarding the patient's concurrent condition, medical history and concomitant medications was provided.  On 05-NOV-2019, the patient was vaccinated with improperly stored hepatitis b vaccine (recombinant) (RECOMBIVAX HB) thimerosal-free, lot # R031052, expiration date 06-MAR-2019, injection (dose, site and route of administration were not provided) for prophylaxis. No adverse effect was reported. The vaccine experienced the temperature 47.1 Fahrenheit degrees for 30 minutes. There was previous temperature excursion 32.9 Fahrenheit degrees for 24 hours. Data logger was involved.  The outcome of the event was unknown.
Vaccine was administered at 0743 and I was monitored for 15 minutes after. I went back to my floor to work. At 11:00 am I noticed my arm was hurting pretty badly. By 11:45am I started feeling bad. I felt dizzy, weak, was flushed,  had a rash/ hives on my neck and chest, and had heart palpitations. I went to my break room to try to eat. I had difficulty eating & took a Benadryl and went immediately to the vaccine administration area at my facility to be monitored. Shortly after I felt my throat & tongue were swelling. After that I was taken to our ER for treatment. By the time I arrived to the ER some of my symptoms had subsided. Those being my heart rate felt ?normal?, my flushing had subsided, and hives were getting somewhat better.  I was given solumedrol, Pepcid, and an IV bolus of fluids & monitored for a few hours. After treatment I felt well enough to be discharged home. Once home I noticed difficulty with swallowing and took another Benadryl and went to bed.
This spontaneous report as received from a physician's assistant refers to patients ages 1 thru 4. The patients were vaccinated with a dose of (Merck) VARIVAX (Lot # not reported). No other co-suspects were reported. No concomitant medications were reported. The physician's assistant reported that he had seen an increase in chicken pox in children age 1 thru 4 who had been vaccinated with (Merck) VARIVAX. The physician's assistant also was seeing natural shingles on the rise in patients. The shingles were not due to any vaccinations. At the time of the report, the patient's outcome was unknown. Additional information is not expected.
Unbearable headaches, sudden onset stage 3 hypertension (BP 250/146), brain aneurysm, stroke, Deterioration of vision, dizziness, seizures and irregular heartbeat
Swelling, redness, tenderness, warmth to touch. Antibiotics given for cellulitis. Warm compresses.
Got one this year with no effect at all with no adverse event; Initial information was received on 06-Nov-2020 regarding an unsolicited valid non-serious case from a consumer (patient) via social media.  This case involves a patient of unknown age who got one this year with no effect at all (drug ineffective), while patient was treated with influenza vaccine.  Past vaccination(s) included influenza vaccine (In the past flu shots made me feel real crappie for a couple of days so patient gave them up).  Medical history, medical treatment(s) and family history were not provided.  Concomitant medication was not reported.  On an unknown date, the patient received influenza vaccine [lot number: unknown and expiration date: unknown] at an unknown dose via an unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date (latency: unknown) after starting the suspect vaccine therapy, patient got one this year with no effect at all (drug ineffective).  No laboratory data was reported.  There will be no information available regarding batch number in this case.
The patient was given the Moderna vaccine and did not meet the minimum age requirement. Patient is 17 and according to Moderna's guidelines the patient must be 18 or older to receive their covid 19 vaccine.  Patient was called twice and a voice mail message was left by the Department Head to contact the clinic. The clinic still has not received a response.
This spontaneous report as received from a nurse refers to an 8 months 2 days old female patient. No concurrent condition, medical history or allergy/drug reactions were reported. On an unspecified date, the patient was vaccinated with improperly stored (exposed to 52.8 Fahrenheit for a total of 105 hours) oral, ROTATEQ lot # K016313, exp. date: 31-MAY-2016 and lot # K011663, exp. date: 20-MAY-2016 (dose and strength unspecified) oral. No concomitant medications were reported. No adverse experiences have been reported so far. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information is not expected, no contact details were provided.
PATIENT REPORTED HEAVY CHEST SENSATION A FEWW MINUTES UPON RECIEVING THE VACCINE AND WENT TO THE er. SINCE THEN HE RECIEVED TEST AND TREATMENT AT THE er. UPON FOLLOW UP CALL WITH PATIENT HE REPORTED TO HAVE HAD, A HEAVY CHEST SENSATION, BURNING FEELING IN THE INSIDE , LIGHT HEADEDNESS AND INCREASED BLOOD PRESSURE.
Information has been received from a registered nurse concerning a 15 year old white female with no allergies and no pertinent medical history who on 10/30/1998 was vaccinated with a first dose of varicella virus vaccine live.  Concomitant vaccine therapy included a first dose of influenza virus split virion 3v vaccine inactivated.  The patient had impetigo and a questionable allergy to milk at the time of vaccination.  It was noted that the patient was exposed to chickenpox at the end of May 2004.  The patient's mother called the physician's office to report that on 06/05/2004 the patient broke out in chickenpox with multiple lesions on her body.  On 06/12/2004 the patient's mother called the physician to report that it looked like bug bites and itchy lesions on her neck.  There was no fever.  On 06/14/2004 the patient's mother noted that there were over 100 lesions and that they were severe.  Unspecified medical attention was sought and no treatment was required.  No lab tests were performed.  Subsequently, the patient recovered.  No product quality complaint was involved.  No further information is expected.
Fatigue, nausea, extreme weakness, briefly unable to move below neck - occurred 2-3 d after administration and progressed over 6-7 hours. Treated at hospital.
68-year-old male with history of tobacco use and left hip surgery of most a year ago on aspirin 81 mg daily presents as a stroke alert left-sided weakness.  His stroke scale on arrival was 9, due to left upper extremity weakness, gaze preference to the right, dysarthria, and left facial droop.  Symptom onset was 1600 this afternoon.  Patient was on a stool and fell due to weakness.  Reports taking aspirin 81 mg every day but denies taking any medications.  States that he did have alcohol today-1 can of Budweiser only.  Denies any other medical history.  Denies being on any other medication.  Patient taken immediately for CT head and found to have right temporal brain bleed.
Pt recvd 1st Engerix-B vax 22MAY91, & 23MAY91 exp "cold-like sx, runny nose & fever; All sx resolved w/in 3 days w/o tx;
Patient received her second dose at 14 days instead of 21 days. Her symptoms included fever, headache, shortness of breath and tightness in her chest.
this is one of four pt from this site to devel a lump @ inject site after recv vax
Patient was given Moderna vaccine ndc 80777-975-05 instead of the updated booster.  No adverse effects reported at this time.
This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine that underwent a temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna Covid-19 vaccine that underwent a temperature excursion) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Jul-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Jul-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine that underwent a temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna Covid-19 vaccine that underwent a temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine that underwent a temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna Covid-19 vaccine that underwent a temperature excursion) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. It was reported that the patient received Moderna Covid-19 vaccine that underwent a temperature excursion. The temperature excursion was not known of at the time of administration of the vaccine. The temperature excursion was found out about after a review of the temperature datalogger on the refrigerator that the Moderna Covid-19 vaccine was stored in. The Nurse has used the online Temperature excursion tool and was comfortable that her patient dose was valid and that the affected vaccine was viable for future doses. Side effects after any doses was unknown. Excursion vaccination date was 08-Jul-2022 with batch number 014B22A. No treatment medications were reported.
I had breast cancer in July, in January I had heart failure which they think its from the Chemotherapy.
She got her vaccine, within a few minutes she felt very weak and felt like she could not move much.  It was difficult for her to catch her breath or take a deep breath and they gave her some juice and asked if her sugar was low.   Her husband took her home.  Was home for about 4 hours, ate lunch and sitting on porch and when her kids were getting baths she felt tired and nauseous.  About an hour she felt like she was going to throw up or faint, and noticed when she went to the bathroom noticed that she had bright red rashes on her face to her shoulders.  Felt shaky and husband got her some juice again, checked her BP which was ok.  They called the doctor and he told her to take twice the amount of her allergy medicine, Claritin and if it didn't get better then go to the ER.   That night she ended up being up all of the night.  Had a lot of pressure in her head, inflamed rash.  Then started having her upper body from about her belly button up to her neck felt sunburned.  She could not even put her back to the chair due to being uncomfortable and did not want to go to the ER due to fear of getting sick.  She had jerking throughout her arms and legs, movement on and off, adn then had shaking tremors.  Had a fever of 103 and had it throughout this entire period and a headache.  She had urgency and was urinating frequently, but was drinking a lot of water and fatigue, more tired than she had ever felt.  She could hardly stand up due to be sick and has small children.  She has never been so sick from anything.     Due to the rash the Dr. would not see her as they told her that it was from the vaccine.  The next day she also got diarrhea.  The shaking and fever for about 24 hours and the sunburn feeling was a few days, the fatigue still continues.   She did have clotting at her period time, which had slowed down and since the vaccine they have not been normal.  She was in tremendous pain about 3 weeks after vaccine, blood clots and still has tremendous pain for a few hours and passes clots.   Her rash was in her face, ear, and then finally was able to see her doctor and could not turn her head the entire way, felt stuck and they decided to check her for Lyme.  She had 4 bands positive for that, and had been tested previously and was negative.  Now she just saw a rheumatologist that kept coming up, joint pains, knee swelling on right knee, left shoulder started being frozen.  Diagnosed with ankylosing spondylitis in October.  She hasn't gotten back to see her doctor yet.  She had seen a rheumatologist 5 years and everything was OK.  Her ESR is now 43 with inflammation in her body that they do not know where it is since the vaccine.     Cognitively she has her days that she is not able to do as much as she wants to do, slower on concentration.    Feels that the vaccine itself has to be looked at for autoimmune over reacting.  If you have had an autoimmune issue and symptoms have diminished, the vaccine seems to heighten the reactions or bring them back.   Also that the vaccine is altering the monthly menstrual cycle.
pt vaxed 17JUN92 & on 18JUN pt presented to MD office w/erythema & swelling 8" x 6 1/2"; area hot to touch; treated w/ice packs; seen by MD 19JUN; area larger than previous day;
pt recv vax 430PM & by that noc,running fever of 103-104 x 6days;seen by MD-no ear infect,no red throat,rx w/sponge baths,APAP;dx w/roseola/3d measles/red rash,virus;
Shaking, throwing up, chills, aches, pains, fever 102, sweating. I gained 11 lbs in 4 days went to urgent care Dr gave me prednisone 20 mg to remove weight gain which I lost 7 lbs overnight. I got rest and felt better after 7 days and arm was red and swollen for 6 days.
Urticarial rash started 8/31/06 48hrs post vaccines. Treated with Benadryl/hydrocortisone, no improvement. Started prednisolone 9/6/06.
Itchiness; Redness; Rash; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE RASH (Rash) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE RASH (Rash). At the time of the report, VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE RASH (Rash) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Treatment medication reported was cortisone.
Fever 102 - large hives at site of injection - myalgias and arthralgias
Patient developed chest pain after vaccine and came to hospital with MI. Had cardiac catheterization which showed occluded LAD and had drug eluting stent to LAD